Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Total Current Liabilities (2018 - 2025)

Inventiva (IVA) posted quarterly Total Current Liabilities of $90.1 million for Q4 2025, down 30.18% year-over-year from $129.0 million in Q4 2024, and down 99.86% quarter-over-quarter from $66.2 billion in Q2 2025.

Analysis

Inventiva (IVA) Total Current Liabilities (2018 - 2025) Analysis & Trends

Inventiva's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $90.1 million for Q4 2025.

  • In Q4 2025, Total Current Liabilities fell 30.18% year-over-year to $90.1 million; the TTM figure through Dec 2025 stood at $90.1 million (down 30.18% YoY), while the FY2025 annual figure was $90.1 million, down 30.18% from the prior year.
  • Total Current Liabilities for Q4 2025 stood at $90.1 million, down from $66.2 billion in the prior quarter.
  • The five-year high for Total Current Liabilities was $66.2 billion in Q2 2025, with the low at $20460.9 in Q2 2024.
  • The 5-year median for Total Current Liabilities is $36.2 million (2022), against an average of $7.7 billion.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities slumped 99.95% in 2024, then surged 323408039.58% in 2025.
  • Inventiva's Total Current Liabilities stood at $26.1 million in 2021, then increased by 19.81% to $31.3 million in 2022, then surged by 72.29% to $54.0 million in 2023, then surged by 139.06% to $129.0 million in 2024, then tumbled by 30.18% to $90.1 million in 2025.
  • Business Quant data shows IVA's Total Current Liabilities at $90.1 million in Q4 2025, $66.2 billion in Q2 2025, and $129.0 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Inventiva 893.85 Mn 893.85 Mn - 90.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 90.07 Mn
Jun 30, 2025 66.17 Mn
Dec 31, 2024 129.01 Mn
Jun 30, 2024 20,460.86
Dec 31, 2023 53.97 Mn
Jun 30, 2023 41.16 Mn
Dec 31, 2022 31.32 Mn
Jun 30, 2022 25.66 Mn
Dec 31, 2021 26.14 Mn
Jun 30, 2021 17.91 Mn
Mar 31, 2021 19.38 Mn
Dec 31, 2020 16.58 Mn
Jun 30, 2020 27.76 Mn
Dec 31, 2019 15.35 Mn
Dec 31, 2018 17.21 Mn